Clinical Trials Conditions Events Microdosing 
The Cannigma
DECEMBER 12, 2022
And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. What is microdosing? How do psychedelics work?
Cannabis Law Report
FEBRUARY 9, 2022
These are the very first draft rules that we’re seeing, so it really is a kind of pivotal event.”. There’s also concern about a rare condition known as wood lover’s paralysis , a condition that produces muscle weakness a few hours after hallucinogenic mushrooms are consumed. Other species might be introduced later.
Cannabis Law Report
JUNE 4, 2021
Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Dr Rosalind Watts is a clinical psychologist, and the clinical lead of the Psilocybin for Depression trial at Imperial College London.
Expert insights. Personalized for you.
119 
Let's personalize your content